Showing results (471-480 of 726) with videos related to
Sort By:
Pageof 73
Journal of the American College of Radiology : JACR|November 2, 2024
ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update, Samantha J Barker, Esra Soylu, et al.European Journal of Radiology|June 23, 2023
American College of Radiology initiatives on prostate magnetic resonance imaging qualityAndrei S Purysko, Clare Tempany, Katarzyna J Macura, et al.European Urology|June 19, 2016
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate CancerAnwar R Padhani, Frederic E Lecouvet, Nina Tunariu, et al.Pediatric Blood & Cancer|September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromasAeRang Kim, Eva Dombi, Kathleen Tepas, et al.EJNMMI Research|November 5, 2024
An automated pheochromocytoma and paraganglioma lesion segmentation AI-model at whole-body 68Ga- DOTATATE PET/CTFahmida Haque, Jorge A Carrasquillo, Evrim B Turkbey, et al.Journal of the American College of Radiology : JACR|November 2, 2024
ACR Appropriateness Criteria® Acute Onset of Scrotal Pain-Without Trauma, Without Antecedent Mass: 2024 Update, Marielia Gerena, Brian C Allen, et al.Clinical Imaging|June 25, 2021
A deep-learning based artificial intelligence (AI) approach for differentiation of clear cell renal cell carcinoma from oncocytoma on multi-phasic MRIMoozhan Nikpanah, Ziyue Xu, Dakai Jin, et al.International Journal of Computer Assisted Radiology and Surgery|April 7, 2015
Augmenting MRI-transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility studyFarhad Imani, Bo Zhuang, Amir Tahmasebi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumorsDan M Patterson, Martin Zweifel, Mark R Middleton, et al.JAMA Network Open|June 13, 2025
AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance ImagesJasper J Twilt, Anindo Saha, Joeran S Bosma, et al.Pageof 73